NCT02790775View on ClinicalTrials.gov

Pain and Visual Outcome in Intravitreal Bevacizumab Injection

PHASE2CompletedINTERVENTIONAL
Enrollment

1,004

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

May 30, 2016

Study Completion Date

August 30, 2016

Conditions
Diabetic Macular Edema
Interventions
DRUG

Anti-VEGF in quadrant 1

DRUG

Anti-VEGF in quadrant 2

DRUG

Anti-VEGF in quadrant 3

DRUG

Anti-VEGF in quadrant 4

Trial Locations (1)

Unknown

Islamic Republic of Iran, Tehran

All Listed Sponsors
lead

Shahid Beheshti University of Medical Sciences

OTHER

NCT02790775 - Pain and Visual Outcome in Intravitreal Bevacizumab Injection | Biotech Hunter | Biotech Hunter